Loading...
XJPX2372
Market cap215mUSD
Jan 17, Last price  
2,788.00JPY
1D
0.07%
1Q
0.25%
Jan 2017
100.00%
Name

I'rom Group Co Ltd

Chart & Performance

D1W1MN
XJPX:2372 chart
P/E
23.85
P/S
1.90
EPS
116.89
Div Yield, %
2.50%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
10.89%
Revenues
17.74b
-3.33%
13,726,000,00014,478,000,00013,815,000,00013,990,000,00011,018,000,0006,704,000,0004,011,000,0004,134,000,0004,114,000,0004,890,000,0008,621,000,00010,578,000,00010,593,000,00012,906,000,00015,693,000,00018,351,000,00017,740,000,000
Net income
1.42b
-44.34%
-1,090,000,000-10,884,000,000-731,000,000226,000,000-364,000,0001,751,000,000-294,000,000-606,000,000-868,000,000204,000,0001,558,000,000912,000,0001,236,000,0001,373,000,0001,961,000,0002,542,000,0001,415,000,000
CFO
446m
-87.48%
-1,339,000,000-780,000,000345,000,000720,000,000-101,000,000-625,000,000-45,000,000-785,000,000-271,000,000-826,000,0001,612,000,000504,000,000637,000,000374,000,0002,630,000,0003,561,000,000446,000,000
Dividend
Mar 28, 202440 JPY/sh

Profile

I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the development of medical technologies, such as regenerative medicine and gene therapy for obstructive arteriosclerosis, retinitis pigmentosa, and human immunodeficiency virus infection and acquired immune deficiency syndrome, as well as Sendai virus vector and CytoTune-iPS, a kit for generating iPS cells. It also supports medical institutions in conducting clinical trials; provides clinical trial support services for new drug development and medical equipment for cancer, and rare and intractable diseases; and establishes and operates clinic malls. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.
URL
https://www.iromgroup.co.jp/
IPO date
Oct 01, 2003
Employees
894
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
17,740,000
-3.33%
18,351,000
16.94%
15,693,000
21.59%
Cost of revenue
16,605,000
10,322,000
9,211,000
Unusual Expense (Income)
NOPBT
1,135,000
8,029,000
6,482,000
NOPBT Margin
6.40%
43.75%
41.31%
Operating Taxes
551,000
789,000
630,000
Tax Rate
48.55%
9.83%
9.72%
NOPAT
584,000
7,240,000
5,852,000
Net income
1,415,000
-44.34%
2,542,000
29.63%
1,961,000
42.83%
Dividends
(845,000)
(603,000)
(480,000)
Dividend yield
3.69%
2.63%
2.06%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
8,914,000
8,680,000
5,126,000
Long-term debt
12,546,000
11,160,000
9,481,000
Deferred revenue
320,000
321,000
Other long-term liabilities
815,000
439,000
403,000
Net debt
11,752,000
5,273,000
4,580,000
Cash flow
Cash from operating activities
446,000
3,561,000
2,630,000
CAPEX
(4,025,000)
(4,167,000)
(2,042,000)
Cash from investing activities
(2,783,000)
(4,842,000)
(2,918,000)
Cash from financing activities
163,000
4,256,000
2,677,000
FCF
(5,907,000)
4,462,000
3,955,000
Balance
Cash
7,236,000
9,386,000
6,400,000
Long term investments
2,472,000
5,181,000
3,627,000
Excess cash
8,821,000
13,649,450
9,242,350
Stockholders' equity
11,700,000
11,081,000
9,117,000
Invested Capital
24,726,000
19,945,000
14,805,000
ROIC
2.61%
41.67%
42.92%
ROCE
3.38%
25.88%
27.10%
EV
Common stock shares outstanding
12,108
12,104
12,096
Price
1,889.00
-0.16%
1,892.00
-1.82%
1,927.00
-21.15%
Market cap
22,871,124
-0.13%
22,899,877
-1.75%
23,308,684
-20.86%
EV
34,623,124
28,178,877
27,904,684
EBITDA
2,271,000
8,826,000
7,089,000
EV/EBITDA
15.25
3.19
3.94
Interest
178,000
146,000
103,000
Interest/NOPBT
15.68%
1.82%
1.59%